• MENU
    LATEST
    AIM
    CURRENT PROJECTS
    TEAM
    PUBLICATIONS
    CONTACT
    Privacy // Cookies
    Outcomes Measurement
    Applied Economic Evaluation & Policy Analysis
    Methods Development
    VIEW ALL
    2021
    2019
    2018
    2017
    2016
    VIEW ALL
    LATEST RESEARCH
    .
    PUBLIC INVOLVEMENT
    2020
    WHAT WE DO

Publications

Home / Publications
  • All Dates
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • Cancer
  • Co-morbidities
  • Cost effectiveness methods
  • EEPRU Reports
  • General Practice
  • Genomics
  • Heterogeneity
  • Implementation
  • Innovation
  • Journal Articles
  • Mental Health
  • Obesity
  • Optimisation
  • Other applied cost effectiveness analyses
  • Outcomes
  • Productivity
  • PROMs
  • ReQoL
  • Shared Decision Making
  • Social Care
  • Value Based Pricing
  • Wellbeing
Economic Evaluation of Social Care Interventions

Economic Evaluation of Social Care Interventions

2015, Cost effectiveness methods, Journal Articles

Faria, R., Kiss, N., Aspinal, F. J., Harden, M. & Weatherly, H. L. A. 25 Dec 2015. Economic [...]

Establishing The Cost-Effectiveness of Genomic-Based Diagnostic Tests: Are Current Methods Sufficient and Appropriate?

Establishing The Cost-Effectiveness of Genomic-Based Diagnostic Tests: Are Current Methods Sufficient and Appropriate?

2015, Genomics, Journal Articles

Spackman E, Hinde S, Bojke L, Payne K, Sculpher MJ. Establishing The Cost-Effectiveness of [...]

Estimating informal care effects associated with EQ-5D for use in economic evaluation. European Journal of Health Economics.

Estimating informal care effects associated with EQ-5D for use in economic evaluation. European Journal of Health Economics.

2015, Journal Articles, Value Based Pricing

Rowen D, Dixon S, Hernandez M, Mukuria C. Estimating informal care effects associated with [...]

Modelling the Cost-Effectiveness of Public Awareness Campaigns for the Early Detection of Non-Small Cell Lung Cancer

Modelling the Cost-Effectiveness of Public Awareness Campaigns for the Early Detection of Non-Small Cell Lung Cancer

2015, Cancer, Journal Articles

Hinde S, McKenna C, Whyte S, Peake MD, Callister MEJ, Rogers T, Sculpher M. Modelling the [...]

Cost-effective analysis of genomic tests: what are the methods challenges?

Cost-effective analysis of genomic tests: what are the methods challenges?

2015, EEPRU Reports, Genomics

Spackman E, Hinde S, Bojke L, Payne K, Sculpher M (2015). Cost-effective analysis of genomic [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix C – Irritable Bowel Disease

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix C – Irritable Bowel Disease

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix D – Epilepsy

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix D – Epilepsy

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix E – Diabetes

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix E – Diabetes

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix F – Bowel Cancer

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix F – Bowel Cancer

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix G – Head and Neck Cancer

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix G – Head and Neck Cancer

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix H – Psychological Therapies

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix H – Psychological Therapies

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix I – Schizophrenia

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix I – Schizophrenia

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix J – Dementia

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix J – Dementia

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix K – Cardiovascular

Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Appendix K – Cardiovascular

2015, EEPRU Reports, PROMs

Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M, Brazier J. (2015). Supporting the [...]

Supporting the routine collection of patient reported outcome measures in the National Clinical Audit Work Package 2.  How should PROMS data be collected?

Supporting the routine collection of patient reported outcome measures in the National Clinical Audit Work Package 2. How should PROMS data be collected?

2015, EEPRU Reports, PROMs

Keetharuth A, Mulhern B, Wong R, Ara R, Franklin M, Jones G, Brazier J. 2015. Supporting the [...]

Estimating the “wider societal impacts” of health conditions and treatments

Estimating the “wider societal impacts” of health conditions and treatments

2015, EEPRU Reports, Social Care

Roberts G. (2015). Estimating the “wider societal impacts” of health conditions and [...]

Estimating an exchange rate between the EQ-5D-3L and ASCOT

Estimating an exchange rate between the EQ-5D-3L and ASCOT

2015, EEPRU Reports, PROMs

Stevens K, Brazier J, Rowen D. Estimating an exchange rate between the EQ-5D-3L and ASCOT. [...]

Economic Analysis to Support NHS Implementation of Hepatitis C Drugs

Economic Analysis to Support NHS Implementation of Hepatitis C Drugs

2015, EEPRU Reports, Implementation, Other applied cost effectiveness analyses

Faria R, Woods B, Griffin S, Palmer S, Ryder S, Sculpher M. Economic Analysis to Support NHS [...]

Economic Analyses to Support NHS Implementation of Hepatitis C Drugs: Scoping Study

Economic Analyses to Support NHS Implementation of Hepatitis C Drugs: Scoping Study

2015, EEPRU Reports, Implementation, Other applied cost effectiveness analyses

Faria R, Barbieri M, Griffin S, Palmer S, Sculpher M. Economic Analyses to Support NHS [...]

A framework for conducting economic evaluations when using patient decision aids in health care decision making

A framework for conducting economic evaluations when using patient decision aids in health care decision making

2015, Cost effectiveness methods, EEPRU Reports, Shared Decision Making

Ara R, Brazier J, Sculpher M, Manca A, Bjoke L, Preston L, Basarir H (2015). A framework for [...]

EEPRU
  • HOME
  • CURRENT PROJECTS
  • PUBLICATIONS
  • CONTACT

Privacy // Cookies // Credits
Copyright All Rights Reserved © 2018
This site uses cookies: Find out more.